Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Leimberger

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|January 11, 2003
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureWendy A Gattis, Christopher M O'Connor, Jeffrey D Leimberger, et al.
The American Journal of Cardiology|August 29, 2003
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failureG Michael Felker, Wendy A Gattis, Jeffrey D Leimberger, et al.
Circulation. Heart Failure|October 8, 2009
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)Liviu Klein, Barry M Massie, Jeffrey D Leimberger, et al.
Journal of the American College of Cardiology|March 26, 2003
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF studyG Michael Felker, Raymond L Benza, A Bleakley Chandler, et al.
Journal of Cardiac Failure|December 16, 2004
Risk stratification after hospitalization for decompensated heart failureG Michael Felker, Jeffrey D Leimberger, Robert M Califf, et al.
The American Journal of Cardiology|July 7, 2009
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)Robert M Califf, Yuliya Lokhnygina, Eric J Velazquez, et al.
Circulation|May 4, 2005
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) studyLiviu Klein, Christopher M O'Connor, Jeffrey D Leimberger, et al.
Journal of the American Heart Association|June 30, 2016
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial InfarctionRenato D Lopes, Karen S Pieper, Susanna R Stevens, et al.
Clinical Trials (London, England)|July 25, 2022
Fitness of real-world data for clinical trial data collection: Results and lessons from a HARMONY Outcomes ancillary studyBradley G Hammill, Jeffrey D Leimberger, Zachary Lampron, et al.
The American Journal on Addictions|December 7, 2007
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) studyRobert L Hubbard, Jeffrey D Leimberger, Louise Haynes, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|January 11, 2003
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureWendy A Gattis, Christopher M O'Connor, Jeffrey D Leimberger, et al.
The American Journal of Cardiology|August 29, 2003
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failureG Michael Felker, Wendy A Gattis, Jeffrey D Leimberger, et al.
Circulation. Heart Failure|October 8, 2009
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)Liviu Klein, Barry M Massie, Jeffrey D Leimberger, et al.
Journal of the American College of Cardiology|March 26, 2003
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF studyG Michael Felker, Raymond L Benza, A Bleakley Chandler, et al.
Journal of Cardiac Failure|December 16, 2004
Risk stratification after hospitalization for decompensated heart failureG Michael Felker, Jeffrey D Leimberger, Robert M Califf, et al.
The American Journal of Cardiology|July 7, 2009
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)Robert M Califf, Yuliya Lokhnygina, Eric J Velazquez, et al.
Circulation|May 4, 2005
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) studyLiviu Klein, Christopher M O'Connor, Jeffrey D Leimberger, et al.
Journal of the American Heart Association|June 30, 2016
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial InfarctionRenato D Lopes, Karen S Pieper, Susanna R Stevens, et al.
Clinical Trials (London, England)|July 25, 2022
Fitness of real-world data for clinical trial data collection: Results and lessons from a HARMONY Outcomes ancillary studyBradley G Hammill, Jeffrey D Leimberger, Zachary Lampron, et al.
The American Journal on Addictions|December 7, 2007
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) studyRobert L Hubbard, Jeffrey D Leimberger, Louise Haynes, et al.
Pageof 3